×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Valamehr Bahram

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJan 09, 2024Sale$4.3811,27149,367158,069Jan 10, 2024, 04:30 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJan 12, 2023Option Exercise$1.37423580169,340Jan 13, 2023, 04:02 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJan 10, 2023Sale$5.2410,91757,205168,917Jan 11, 2023, 04:08 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJul 07, 2022Option Exercise$2.7317,15846,841196,992Jul 08, 2022, 04:51 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJul 07, 2022Sale$30.2317,158518,686179,834Jul 08, 2022, 04:51 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJul 06, 2022Option Exercise$3.277,84225,629187,676Jul 07, 2022, 04:04 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJul 06, 2022Sale$30.077,842235,809179,834Jul 07, 2022, 04:04 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerMar 14, 2022Option Exercise$2.7325,00068,250204,834Mar 15, 2022, 04:27 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerMar 14, 2022Sale$31.0725,000776,733188,156Mar 15, 2022, 04:27 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJan 11, 2022Sale$48.504,570221,655146,950Jan 13, 2022, 04:07 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerJan 10, 2022Sale$46.385,596259,558151,453Jan 12, 2022, 04:05 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerDec 13, 2021Option Exercise$2.7325,00068,250181,698Dec 14, 2021, 04:18 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief R&D OfficerDec 13, 2021Sale$47.6625,0001,191,406179,598Dec 14, 2021, 04:18 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerSep 13, 2021Option Exercise$2.7325,00068,250120,740Sep 14, 2021, 04:01 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerSep 13, 2021Sale$66.2925,0001,657,257104,931Sep 14, 2021, 04:01 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerMar 15, 2021Sale$92.3525,0002,308,772116,783Mar 16, 2021, 04:05 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerMar 15, 2021Option Exercise$2.9025,00072,500120,740Mar 16, 2021, 04:05 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerJan 08, 2021Sale$117.106,230729,55284,455Jan 12, 2021, 08:40 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerJan 11, 2021Sale$110.813,254360,58879,649Jan 12, 2021, 08:40 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerDec 14, 2020Option Exercise$2.9025,00072,500112,211Dec 15, 2020, 04:01 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerDec 14, 2020Sale$97.7825,0002,444,477110,398Dec 15, 2020, 04:01 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerSep 14, 2020Option Exercise$2.7525,00068,778112,211Sep 16, 2020, 04:02 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerSep 14, 2020Sale$36.2825,000907,024111,611Sep 16, 2020, 04:02 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerFeb 03, 2020Option Exercise$1.691,1531,94987,211Feb 04, 2020, 12:00 AM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerJan 08, 2020Sale$20.695,700117,94786,058Jan 10, 2020, 04:03 PM
FATEFATE THERAPEUTICS INCValamehr BahramChief Development OfficerOct 15, 2019Sale$14.186,20087,89166,758Oct 16, 2019, 04:06 PM